Inventor · disambiguated record
Mark A. Exley
Also filed as: EXLEY MARK · EXLEY MARK A · EXLEY MARK ADRIAN
17 granted patents·25 pending applications·292 citations·filing 1995–2023
93Inventor score
Files withXENOVA RES LTD12IMMULOGIC PHARMA CORP5EXLEY MARK A4HYDROXSYS HOLDINGS LTD4MINK THERAPEUTICS INC4
Top patents by PatentIndex Score
42 records- 0190US5876727AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC PHARMA CORP·Filed 1996·Granted Mar 2, 1999·115 cites·18 claims
- 0285US8138314B2Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulationsEXLEY MARK A·Filed 2006·Granted Mar 20, 2012·12 cites·13 claims
- 0380US5760184AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC PHARMA CORP·Filed 1995·Granted Jun 2, 1998·36 cites·8 claims
- 0478US5773003AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC INC·Filed 1995·Granted Jun 30, 1998·37 cites·12 claims
- 0576US11718658B2T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereofMINK THERAPEUTICS INC·Filed 2020·Granted Aug 8, 2023·1 cites·21 claims
- 0672US5840307AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparationIMMULOGIC PHARMA CORP·Filed 1995·Granted Nov 24, 1998·21 cites·3 claims
- 0770US12391741B2T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereofMINK THERAPEUTICS INC·Filed 2023·Granted Aug 19, 2025·0 cites·20 claims
- 0870US10335742B2Asymmetric composite membranes and modified substrates used in their preparationHYDROXSYS HOLDINGS LTD·Filed 2015·Granted Jul 2, 2019·1 cites·7 claims
- 0968US6982326B1Allergenic proteins and peptides from Japanese cedar pollenIMMULOGIC PHARMA CORP·Filed 1999·Granted Jan 3, 2006·27 cites·18 claims
- 1068US2006286096A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1168US2006280736A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1268US2006286099A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1368US2006286097A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1468US2006286095A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1568US2006280735A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 1667US6054127AHapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameIMMULOGIC PHARMA CORP·Filed 1997·Granted Apr 25, 2000·27 cites·7 claims
- 1767US2010105672A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameSWAIN PHILIP A·Filed 2009·Application pending·0 cites
- 1867US2010068222A1Hapten-carrier conjugates for use in drug abuse therapy and methods for preparation of sameSWAIN PHILIP A·Filed 2009·Application pending·0 cites
- 1964US2006286094A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 2064US2024102044A1T cell receptors that bind to ny-eso-1 and methods of use thereofMINK THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2164US2006058220A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2005·Application pending·0 cites
- 2263US2010209449A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameSWAIN PHILIP A·Filed 2010·Application pending·0 cites
- 2362US11291215B2Durable asymmetric composite membranes and modified substrates used in their preparationHYDROXSYS HOLDINGS LTD·Filed 2019·Granted Apr 5, 2022·0 cites·5 claims
- 2462US2005124061A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2003·Application pending·0 cites
- 2561US11613764B2T cell receptors that bind to NY-ESO-1 and methods of use thereofMINK THERAPEUTICS INC·Filed 2019·Granted Mar 28, 2023·0 cites·8 claims
- 2661US8084020B2Use of anti-CD1 antibodies for the modulation of immune responsesEXLEY MARK A·Filed 2003·Granted Dec 27, 2011·3 cites·6 claims
- 2761US2006286098A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 2858US9907848B2Methods and compositions for treatment of metabolic disordersBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2013·Granted Mar 6, 2018·0 cites·10 claims
- 2958US2006239997A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2006·Application pending·0 cites
- 3058US2015299320A1Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulationsBETH ISRAEL HOSPITAL·Filed 2014·Application pending·0 cites
- 3158US2002032316A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameCANTAB PHARMACEUTICALS RES LTD·Filed 2001·Application pending·0 cites
- 3257US8540999B2Allergenic proteins and peptides from Japanese cedar pollenGRIFFITH IRWIN J·Filed 2004·Granted Sep 24, 2013·0 cites·2 claims
- 3353US2003069400A1Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of sameXENOVA RES LTD·Filed 2002·Application pending·0 cites
- 3452US2015231234A1Use of anti-cd1 antibodies for the modulation of immune responsesBETH ISRAEL HOSPITAL·Filed 2014·Application pending·0 cites
- 3551US2012258040A1Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulationsEXLEY MARK A·Filed 2012·Application pending·0 cites
- 3649US2022193620A1Asymmetric composite membranes and modified substrates used in their preparationHYDROXSYS HOLDINGS LTD·Filed 2022·Application pending·0 cites
- 3748US6090386AT cell peptides of the CRX JII allergenFiled 1995·Granted Jul 18, 2000·12 cites·5 claims
- 3847US11389771B2Asymmetric composite membrane and a method of preparation thereofHYDROXSYS HOLDINGS LTD·Filed 2016·Granted Jul 19, 2022·0 cites·10 claims
- 3945US2002164331A1Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulationsFiled 2001·Application pending·0 cites
- 4044US2012164138A1Use of anti-cd1 antibodies for the modulation of immune responsesEXLEY MARK A·Filed 2011·Application pending·0 cites
- 4141US2018296671A1Methods and compositions for treatment of metabolic disordersBETH ISRAEL DEACONESS MEDICAL CT INC·Filed 2018·Application pending·0 cites
- 4239US2009068210A1Immunotherapy for hematological malignanciesMUNSHI NIKHIL C·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →